Greco Marianna, Caocci Giovanni, Ledda Antonio, Vacca Adriana, Arras Marcella, Celeghini Ivana, La Nasa Giorgio
Hematology Unit and Bone Marrow Transplantation Center, "R. Binaghi" Hospital, Via Is Guadazzonis 3, 09126 Cagliari, Italy.
Case Rep Hematol. 2013;2013:896394. doi: 10.1155/2013/896394. Epub 2013 Jul 7.
Despite major advances in the treatment of acute promyelocytic leukemia (APL), the problem of early death (ED) remains unsolved. Alongside the currently known clinical and hematological risk factors, prognostic significance has been attributed to internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD), hypogranular variant morphology, and the bcr-3 isoform of PML-RAR α . We describe premature death of two patients with the hypogranular variant of APL who presented remarkably high expression levels of Wilms' tumor gene (WT1). Our results point to WT1 as an important prognostic factor of ED that needs to be promptly evaluated in all newly diagnosed cases of APL.
尽管急性早幼粒细胞白血病(APL)的治疗取得了重大进展,但早期死亡(ED)问题仍未解决。除了目前已知的临床和血液学危险因素外,FMS样酪氨酸激酶3(FLT3-ITD)的内部串联重复突变、低颗粒变异形态以及PML-RARα的bcr-3亚型也具有预后意义。我们描述了两名APL低颗粒变异型患者的过早死亡,他们的威尔姆斯瘤基因(WT1)表达水平显著升高。我们的结果表明,WT1是ED的一个重要预后因素,需要在所有新诊断的APL病例中及时进行评估。